ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FIRAS KARA M.D.

Internal Medicine

757

$63.6K

191
28 are 65+

69%
patients receiving schedule two controlled substances

Avg: 6%

32%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $61

MARK LAFLAMME M.D.

Internal Medicine

1,614

$101K

78
21 are 65+

76%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $61

ALVARO LAPITZ

Internal Medicine

1,102

$103K

214
89 are 65+

43%
patients receiving schedule two controlled substances

Avg: 6%

43%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $61

PALMER MACKIE MD

Internal Medicine

3,648

$210K

213
76 are 65+

50%
patients receiving schedule two controlled substances

Avg: 6%

35%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

JAMES HAMAKER MD

Internal Medicine

2,436

$140K

239
100 are 65+

37%
patients receiving schedule two controlled substances

Avg: 6%

40%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

LINDA ROSENBERG DO

Internal Medicine

2,583

$108K

186
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

62%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $61

ROBERT WALTON M.D.

Internal Medicine

234

$3,810

150
64 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

52%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $61

RHODA LYN AURE MD

Internal Medicine

2,334

$161K

351
84 are 65+

44%
patients receiving schedule two controlled substances

Avg: 6%

34%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $61

GARETH GILKEY MD

Internal Medicine

8,183

$385K

652
276 are 65+

34%
patients receiving schedule two controlled substances

Avg: 6%

33%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

MARIA ROBLES MD

Internal Medicine

3,364

$210K

280
109 are 65+

37%
patients receiving schedule two controlled substances

Avg: 6%

33%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

LINAS SIMONAITIS

Internal Medicine

2,701

$185K

256
94 are 65+

35%
patients receiving schedule two controlled substances

Avg: 6%

32%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

LARRY BLEDSOE MD

Internal Medicine

7,790

$462K

246
111 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

54%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

JULIE VANNERSON MD

Internal Medicine

3,558

$219K

292
105 are 65+

35%
patients receiving schedule two controlled substances

Avg: 6%

32%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

PETER SCHWARTZ MD

Internal Medicine

3,146

$161K

147
70 are 65+

32%
patients receiving schedule two controlled substances

Avg: 6%

35%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

ROBERT CHUA M.D.

Internal Medicine

17,102

$1.1M

331
154 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

45%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

TIMOTHY BRADY MD

Internal Medicine

1,449

$89K

72
36 are 65+

26%
patients receiving schedule two controlled substances

Avg: 6%

35%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

JIP YOON M.D.

Internal Medicine

1,390

$79.5K

68
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

57%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

TIMOTHY WALBRIDGE MD

Internal Medicine

4,443

$350K

133
85 are 65+

35%
patients receiving schedule two controlled substances

Avg: 6%

37%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $61

BACHAR MALEK M.D.

Internal Medicine

10,873

$628K

384
186 are 65+

27%
patients receiving schedule two controlled substances

Avg: 6%

39%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

NEDU GOPALA M.D.

Internal Medicine

8,864

$467K

232
70 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

47%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

PATRICE CATES-LONBERGER MD

Internal Medicine

2,753

$173K

269
102 are 65+

24%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $61

SARAH DAVIDSON MD

Internal Medicine

2,701

$160K

179
90 are 65+

22%
patients receiving schedule two controlled substances

Avg: 6%

36%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

KATHERINE GILKEY MD

Internal Medicine

751

$36.3K

166
59 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

CHRISTOPHER STEINMETZ MD

Internal Medicine

12,721

$687K

1019
446 are 65+

29%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

SAMUEL HOLLINGSWORTH M.D.

Internal Medicine

9,190

$474K

363
224 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

38%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank